Interstitial Lung Disease Latest Advances

Type 2 inflammation and biologics: a twenty-year journey.

Journal: Expert opinion on biological therapy

Published: June 24, 2026

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Journal: Pulmonology

Published: June 24, 2026

Solitary gastric langerhans cell histiocytosis treated by endoscopic submucosal dissection: A case report and literature review.

Journal: Science progress

Published: June 23, 2026

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

Journal: Physics in medicine and biology

Published: June 23, 2026

A profile on inhaled treprostinil for pulmonary hypertension.

Journal: Expert review of respiratory medicine

Published: June 23, 2026

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Clinical presentations of the most common histiocytic disorders.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: June 22, 2026

Local EETs Formation in Granulomatous Arteritis in a Patient With Eosinophilic Granulomatosis With Polyangiitis.

Journal: The American Journal of dermatopathology

Published: June 22, 2026

Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires

Journal: Medicina

Published: June 22, 2026

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Journal: Respiratory medicine

Published: June 21, 2026

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Journal: Expert review of anticancer therapy

Published: June 20, 2026

An update on the pharmacological management of ANCA vasculitis.

Journal: Expert review of clinical immunology

Published: June 20, 2026

Interstitial Lung Disease Latest Advances

Find the Latest Research About Interstitial Lung Disease

Type 2 inflammation and biologics: a twenty-year journey.

Type 2 inflammation and biologics: a twenty-year journey.

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Solitary gastric langerhans cell histiocytosis treated by endoscopic submucosal dissection: A case report and literature review.

Solitary gastric langerhans cell histiocytosis treated by endoscopic submucosal dissection: A case report and literature review.

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

A profile on inhaled treprostinil for pulmonary hypertension.

A profile on inhaled treprostinil for pulmonary hypertension.

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Clinical presentations of the most common histiocytic disorders.

Clinical presentations of the most common histiocytic disorders.

Local EETs Formation in Granulomatous Arteritis in a Patient With Eosinophilic Granulomatosis With Polyangiitis.

Local EETs Formation in Granulomatous Arteritis in a Patient With Eosinophilic Granulomatosis With Polyangiitis.

Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires

Clinical and functional characteristics of patients with interstitial lung disease and pulmonary hypertension from a specialized lung disease center in Buenos Aires

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

An update on the pharmacological management of ANCA vasculitis.

An update on the pharmacological management of ANCA vasculitis.